SCHEMBL29552236

SCHEMBL29552236

CC(C)(C)OC(=O)c1cccc(Nc2cc(-c3c(F)cccc3F)nnc2C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.43
▸ ABCG2 Q9UNQ0 1/20 0.43
▸ F2 P00734 5/20 0.41
▸ TMPRSS6 Q8IU80 2/20 0.41
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ DHODH Q02127 1/20 0.39
▸ JAK2 O60674 5/20 0.38
▸ JAK1 P23458 4/20 0.38
▸ TYK2 P29597 4/20 0.38
▸ JAK3 P52333 2/20 0.38
▸ SLC7A5 Q01650 1/20 0.38
▸ BUB1 O43683 1/20 0.38
▸ CDC25B P30305 1/20 0.36
▸ AKR1C3 P42330 1/20 0.36
▸ AKR1C2 P52895 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28358863 0.92 ABCB1 (0.41) ABCB1ABCG2F2TMPRSS6NPC1
SCHEMBL29552248 0.92 ABCB1 (0.41) ABCB1ABCG2F2TMPRSS6NPC1
SCHEMBL29922466 0.92 ABCB1 (0.41) ABCB1ABCG2F2TMPRSS6NPC1
SCHEMBL29551854 0.91 JAK1 (0.47) ABCB1ABCG2F2TMPRSS6NPC1
SCHEMBL28358981 0.91 JAK1 (0.47) ABCB1ABCG2F2TMPRSS6NPC1
SCHEMBL29551766 0.85 JAK2 (0.51) ABCG2F2TMPRSS6ALDH1A1MAPT
SCHEMBL29552219 0.84 DHODH (0.48) DHODHJAK2JAK1TYK2JAK3
SCHEMBL29552047 0.83 TYK2 (0.48) DHODHJAK2JAK1TYK2JAK3
SCHEMBL28359098 0.83 TYK2 (0.48) DHODHJAK2JAK1TYK2JAK3
SCHEMBL29552243 0.82 ABCB1 (0.47) ABCB1ABCG2F2TMPRSS6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
Send feedback